Full Coverage
AbbVie Strikes Deal to Acquire Allergan for About $63 Billion
By Jonathan D. Rockoff, Dana Cimilluca & Cara Lombardo
Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal (Published 2019)
By Katie Thomas & Michael de la Merced
AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
By Michael Erman, Julie Steenhuysen & Ankur Banerjee
AbbVie (ABBV) to Buy Allergan (AGN) in $63 Billion Deal
By Riley Ray Griffin & Rebecca Spalding